Sofinnova Investments, Inc. Bristol Myers Squibb CO Transaction History

Sofinnova Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $23.5 Million - $30.7 Million	-478,349 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $13 Million - $15.4 Million	304,500 Added 175.15%	478,349 $24.3 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $7.76 Million - $8.58 Million	173,849 New	173,849 $7.88 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $759,617 - $946,778	-15,033 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $900,777 - $1.04 Million	15,033 New	15,033 $951,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.